Sulfatase 3 example sentences

"Sulfatase 3" Example Sentences

1. Sulfatase 3 deficiency is a rare genetic disorder.
2. The study focused on the role of sulfatase 3 in brain development.
3. Researchers are investigating new therapies targeting sulfatase 3 dysfunction.
4. Genetic mutations affecting sulfatase 3 can lead to severe symptoms.
5. Sulfatase 3 activity was significantly reduced in the affected tissue.
6. A novel inhibitor of sulfatase 3 showed promise in preclinical studies.
7. The expression levels of sulfatase 3 varied across different cell types.
8. We measured sulfatase 3 enzyme activity using a specific assay.
9. Deficiency in sulfatase 3 is associated with a range of neurological problems.
10. Understanding the function of sulfatase 3 is crucial for developing effective treatments.
11. The patient presented with symptoms consistent with sulfatase 3 deficiency.
12. Further research is needed to elucidate the precise mechanism of sulfatase 3 action.
13. This study provides new insights into the regulation of sulfatase 3 expression.
14. Inhibition of sulfatase 3 may offer a novel therapeutic strategy.
15. The diagnostic test confirmed a deficiency in sulfatase 3 enzyme activity.
16. Disruption of sulfatase 3 function can lead to developmental delays.
17. Sulfatase 3 plays a vital role in the metabolism of sulfated compounds.
18. The team successfully cloned the gene encoding sulfatase 3.
19. Clinical trials are underway to evaluate potential therapies for sulfatase 3 deficiency.
20. The impact of sulfatase 3 deficiency on cognitive function requires further investigation.
21. Sulfatase 3 is a member of the sulfatase family of enzymes.
22. Aberrant sulfatase 3 activity is implicated in various pathological conditions.
23. Novel substrates for sulfatase 3 were identified using high-throughput screening.
24. The precise substrate specificity of sulfatase 3 remains to be fully characterized.
25. Long-term effects of sulfatase 3 deficiency on patient health are still under study.
26. Genetic testing can be used to identify individuals with sulfatase 3 deficiency.
27. Early diagnosis of sulfatase 3 deficiency is crucial for optimal management.
28. Studies have shown a correlation between sulfatase 3 levels and disease severity.
29. The development of specific sulfatase 3 inhibitors is an active area of research.
30. Sulfatase 3 deficiency is more prevalent in certain populations.
31. Animal models are being used to study the function of sulfatase 3.
32. The role of sulfatase 3 in cellular signaling pathways is being investigated.
33. Research on sulfatase 3 has implications for both basic and translational science.
34. This drug targets sulfatase 3 to improve patient outcomes.
35. The data suggest a link between sulfatase 3 and neurodegeneration.
36. There are currently no FDA-approved treatments specifically targeting sulfatase 3.
37. Future research should explore the potential of gene therapy for sulfatase 3 deficiency.
38. Sulfatase 3 activity is regulated by various post-translational modifications.
39. The study demonstrated a significant reduction in sulfatase 3 expression.
40. Sulfatase 3 is an important enzyme in the lysosomal pathway.
41. Patients with sulfatase 3 deficiency often exhibit a variety of symptoms.
42. The prognosis for sulfatase 3 deficiency depends on the severity of the condition.
43. Sulfatase 3 is localized to the lysosome within the cell.
44. Understanding the three-dimensional structure of sulfatase 3 is crucial for drug design.
45. The team is working on developing a more sensitive assay for sulfatase 3 activity.
46. Improved diagnostic tools are needed for accurate detection of sulfatase 3 deficiency.
47. Research into sulfatase 3 is ongoing worldwide.
48. This is a groundbreaking study on the effects of sulfatase 3 inhibition.
49. The article reviews the current literature on sulfatase 3 and related disorders.
50. Further studies are warranted to investigate the therapeutic potential of sulfatase 3 modulation.